U.S Bacterial Conjun
U.S Bacterial Conjunctivitis Drugs Market Will Reach US& 439.8 Million in 2024 by Persistence Market Research
13 juil. 2015 03h53 HE | Persistence Market Research
New York, July 13, 2015 (GLOBE NEWSWIRE) -- According to a new market report published by Persistence Market Research "The U.S Market Study on Bacterial Conjunctivitis Drugs: fluoroquinolones to be...
Rafarma Pharmaceuticals, Inc. logo
Rafarma Pharmaceuticals (RAFA) Announces New President as Part of Pending Acquisition of Majority Interest
30 juil. 2014 14h40 HE | Rafarma Pharmaceuticals, Inc.
MOSCOW, July 30, 2014 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals Inc. (Pink Sheets:RAFA) announces the appointment of Mr. Bruno Horn, a Swiss citizen, as the new President and Director of the...